CorePharma Revenue and Competitors

CorePharma, founded in 1998, is a developer and manufacturer of high-quality, targeted, branded and generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories. We specialize in difficult-to-develop high value products across a variety of therapeutic areas. CorePharma actively seeks partnerships, licensing and acquisition opportunities. By collaborating with innovative and trusted partners, we maximize the value of the relationship for all parties. CorePharma currently operates three state-of-the-art facilities, totaling 100,000 square feet, in Middlesex, New Jersey. These facilities accommodate all research and development, analytical testing, manufacturing, packaging, and warehousing activities with a capacity of over 2 billion dosage units per year. These facilities are U.S. Food and Drug Administration (FDA) approved and licensed to manufacture and distribute controlled substances, Class C-II through C-V. CorePharma continuously invests in manufacturing, packaging and testing facilities to improve efficiencies, ensure quality, add capacity and enhance technologies. In Jan 2018, CorePharma was acquired by a group of industry investors with the unwavering commitment to remain a trusted, reliable and preferred partner of choice for the Development and Manufacturing of high-quality generic and branded pharmaceuticals.